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Abstract
Background: Cardiac rupture (CR) is a common cause of death following acute myocardial
infarction (AMI). Despite improvements in AMI treatment, the frequency of CR remains
considerable and in most cases leads to death. The aim of the study was to define the independ-
ent prognostic CR risk factors of AMI in patients treated with percutaneous coronary interven-
tion (PCI).
Methods: A total of 4,200 AMI patients treated by PCI were studied retrospectively. Two
hundred and seventy patients who had died of AMI were examined. In all cases CR was
confirmed in post-mortem examination.
Results: Cardiac rupture occurred in 49 patients (18.1%). In the CR group, 24.4% patients
received thrombolysis and 22.6% in the non-CR group (p = NS). The following characteristics
were associated with a higher rate of CR in univariable analysis: age (70.3 ± 3.2 vs. 65.2 ±
± 9.9; p < 0.001), female (75.0% vs. 60.2%; p < 0.001), prior cardiac event and absence of
myocardial infarction history (61.2% vs. 40.2%; p < 0.05 and 14.2% vs. 33.4%; p < 0.05),
presence of QS complex in first ECG (75.5% vs. 52.0%, p < 0.05) and multiple coronary heart
disease (75.5% vs. 61.5%, p < 0.05), and long time from onset of symptoms to thrombolysis and to
PCI (8.1 ± 2.8 vs. 4.7 ± 2.3 hours, p < 0.001 and 9.0 ± 5.5 vs. 4.5 ± 3.2 hours, p < 0.001).
In the multivariable analysis, independent predictors of CR were: age (OR: 1.1; 95% CI: 1.02–
–1.19; p = 0.01); female gender (OR: 0.2; 95% CI: 0.07–0.52; p = 0.001); time from onset of
symptoms to PCI (OR: 1.15; 95% CI: 1.07–1.47; p = 0.003).
Conclusions: Old age, female gender and long time from onset of symptoms to AMI treatment
(independent of previous fibrinolysis) are independent factors of CR in PCI patients. (Cardiol J
2007; 14: 538–543)
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Introduction
Nowadays we can observe a systematic in-
crease in the total number of percutaneous trans-
luminal intervention (PCI) patients, also as a meth-
od of acute myocardial infarction (AMI) treatment.
This has improved the results of AMI treatment as
defined by in-hospital and long-term mortality [1–3].
Despite all of these methods, there are AMI
complications which are difficult to predict and treat.
One of these complications is cardiac rupture (CR).
The majority of CR complicated cases lead to death,
most of them being recognised in postmortem ex-
aminations. The risk factors of CR before PCI in
AMI treatment are known — female gender, old
age, prior coronary heart disease (CHD), absence
of AMI in the past, arterial hypertension (HA) and
one-vessel coronary artery disease (CAD) [4–12].
There is also analysis which estimates the risk
of CR in patients undergoing PCI in AMI compared
to those treated with thrombolysis. According to
Moreno [13], old age, female gender and anterior
location have been postulated; however, the advan-
tage of PCI has been confirmed as a protective fac-
tor against CR.
In contrast to other investigations, all AMI pa-
tients in our study had been treated with PCI. In
some cases, fibrinolysis had been used previously.
The objective of this study was to isolate CR risk
factors in patients with AMI treated with PCI.
Methods
A total of 4,200 consecutive AMI patients treat-
ed by PCI at our institute within 12 hours of the
onset of symptoms were studied retrospectively.
We analysed 270 patients who died from AMI. PCI
had been performed on all patients. CR was found
in 49 patients, which was confirmed in post-mor-
tem examinations and in most cases also by echo-
examination. The status of the CAD history was
known from the patients’ previous histories. Pa-
tients were considered to have diabetes if they had
been diagnosed or if they were being treated with
either insulin or oral drugs. Patients were consid-
ered to have hypertension if they had been diag-
nosed or if they were receiving antihypertensive
drugs.
All the analysed patients received aspirin 325–
–500 mg and heparin 500–1000 IU, administered in-
travenously. Sixty-two (22.9%) of the CR patients
were treated with thrombolytic agents before PCI.
Glycoprotein Ilb/IIIa inhibitors were administered
in 72 (26.6%) patients. Coronary stents were used
in the case of essential coronary artery stenosis or
its dissection.
Despite the identification of infarct related ar-
tery, angiography of other coronary arteries was
also performed to assess the presence of any mul-
tivessel CHD.
We provided a comparative analysis between
CR and non-CR patients by considering demograph-
ic data, concomitant diseases, the course and meth-
ods of AMI treatment and patients’ coronary histo-
ry. We selected independent CR risk factors from
all the available factors. Moreover, from the CR
group we selected patients who had been treated
with thrombolysis before PCI in order to determine
independent CR risk factors in such a group and to
check if they differed from other CR patients.
Statistical analysis
The means of normally distributed variables
were compared by using the student t-test. For
comparison of the distribution of risk factors be-
tween groups, c2 analysis was used. Independent CR
risk factors were calculated using uni- and multi-
variable logistic regression models. Descriptive
statistics are expressed as mean ± SD.
Results
Baseline characteristics in both groups are pre-
sented in Table 1. CR patients were older, present-
ed more frequently female gender, QS complex in
the first ECG and the presence of multivessel CHD,
had neither a history of AMI nor cardiac events and
had had a longer time from the onset of symptoms
to both thrombolysis and PCI. CR was present in
18.1% of patients who died from AMI. Thirty-six
patients (73.4%) presented acute CR (Table 1).
In the multivariable analysis, three parameters
were found as independent predictors of CR: age,
[odds ratio (OR): 1.1; 95% confidence interval (CI):
1.02–1.19; p = 0.01], female gender (OR: 0.2; 95%
CI: 0.07–0.52; p = 0.001), and time from onset of
symptoms to PCI (OR: 1.15; 95% CI: 1.07–1.47;
p = 0.003). Results of multivariable analysis are
presented in Table 2.
Based on the above results, we are able to es-
timate the probability of CR in AMI patients with
more than one CR independent factor. As an exam-
ple, we present the probability of CR risk in a pa-
tient using the two CR risk factors: age and time of
AMI pain (Fig. 1).
For a 70-year-old patient regardless of gender,
who presents 12 hours of AMI pain, the probability
of CR is 0.20. Moreover, we attempted to estimate
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the probability of CR only in women recording two
independent CR risk factors: age and time of AMI
pain (Fig. 2).
For a 70-year-old woman who presents
12 hours of AMI pain, the probability of CR is 0.30.
In multivariable analysis, for CR patients who re-
ceived thrombolysis before PCI, the only independ-
ent risk factor was the long time from the onset
of symptoms to PCI (OR: 1.7; 95% CI: 1.2–2.4;
p < 0.001).
Discussion
Despite improvements in AMI treatment, the
incidence of CR remains significant. The frequen-
cy of CR in this study was 18.1%, which is compa-
rable with data from studies of patients treated con-
servatively or with fibrinolysis [7, 13–24].
The recognition of CR risk factors in AMI pa-
tients treated with PCI may have important clini-
cal implications. It would allow us to select patients
with an increased risk of CR who require special
supervision. We could also question whether inva-
sive methods of AMI treatment are suitable for all
patients and whether or not we can do anything
more to avoid CR.
Multivariable analysis showed that old age was
an independent CR risk factor, as did most other
investigators [7, 13, 23–28]. The presumed mech-
anism of increased risk of CR in elderly patients is
organic lesions of the myocardium. This makes the
myocardium less resistant to mechanical factors,
such as sudden ischemia.
In our study, all the cases of CR examined were
confirmed in post-mortem examinations. In the
SHOCK Trial Registry, for example, only 9 out of
Table 1. Comparison of clinical features of cardiac rupture (CR) and non-cardiac rupture (non-CR)
patients.
CR Non-CR p
Age 70.3 ± 3.2 65.2 ± 9.9 < 0.001**
Female 37 (75.0%) 88 (60.2%) < 0.001*
Male  12 (25%) 133 (39.8%)
Arterial hypertension 20 (40.8%) 121 (54.7%) NS*
Diabetes mellitus 15(30.6%) 71 (32.1%) NS*
Prior cardiac event 30 (61.2%) 89 (40.2%) < 0.05*
Myocardial infarction in the past 7 (14.2%) 74 (33.4%) < 0.05*
QS complex 37 (75.5%) 115 (52.0%) < 0.05
Multiple coronary artery disease 38 (77.5%) 136 (61.5%) < 0.05
Time from onset of symptoms to PCI [h] 9.0 ± 5.5 4.5 ± 3.2 < 0.001
Anterior wall acute myocardial infarction 30 (61.2%) 129 (58.3%) NS*
ST depressions 27 (55.1%) 110 (49.7%) NS*
Time from onset of symptoms to fibrinolysis [h] 8.1 ± 2.8 4.7 ± 2.3 < 0.001**
Successful PCI 29 (59.1%) 118 (53.3%) NS*
Fibrinolysis 12 (24.4%) 50 (22.6%) NS*
IIb/IIIa blocker 10 (20.4%) 62 (28.0%) NS*
*c analysis, **student t-test; PCI — percutaneous coronary intervention
Table 2. Results of multivariable analysis.
Age Sex Time QS MI Prior Multiple
to PCI complex in the past CAD CAD
P 0.01 0.001 0.003 0.17 0.84 0.07 0.13
Odds ratio 1.1 0.2 1.25 1.82 0.89 2.39 2.05
–95% confidence interval 1.02 0.07 1.07 0.76 0.27 0.92 0.8
+95% confidence interval 1.19 0.52 1.47 4.36 2.86 6.22 5.25
PCI — percutaneous coronary intervention; MI — myocardial infarction; CAD — coronary artery disease
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the 28 cases classified as CR presented cardiac tam-
ponade in the absence of a left ventricle rupture [17].
In our data we found that CR occurred significant-
ly more often in females, which in fact was also
pointed out by other investigators [7, 13, 19, 22, 28].
This can be explained by the observation that fe-
males have AMI more often as a first symptom of
CAD. Our analysis of patient coronary histories
showed that the presence of previous MI was sig-
nificantly the most frequent prior cardiac event in
CR patients. However, the patients in the non-CR
group had had MI more often in the past. These re-
lationships were also observed by other investiga-
tors [7, 17, 28], something which has been associ-
ated with the preconditioning effect. The compara-
tive analysis showed that the time from the onset
of AMI symptoms to both fibrinolysis and PCI were
significantly longer in CR. Moreover, in the multi-
variable analysis, a long time to PCI was an inde-
pendent CR risk factor. Based on these results we
conclude that independently of the mechanism lead-
ing to the revascularization, a long time to revascu-
larisation tended to CR. Moreno et al. [27] also pos-
tulated the role of early revascularisation as a CR pro-
tective factor — according to them, treatment over
2 hours was associated with a higher rate of CR.
In our data, considering the time to AMI treat-
ment, we found that time over 6 hours significantly
increases CR risk. Based on this, we concluded that
reducing the incidence of CR might be obtained by
early reperfusion. Considering the presence of the
QS complex in ECG, which may be an expression
of prolonged AMI, we observed its presence signif-
icantly more often in CR patients. This fact was also
observed in the SHOCK Trial and is related to pro-
longed AMI [29]. Using angiographic data of coro-
nary arteries we found that in the CR group, multi-
vessel CAD was present significantly more often.
Our findings are not confirmed by other investiga-
tors’ results which supposed the hypothesis of col-
lateral circulation in one-vessel CAD. This was ex-
plained as an outcome of a myocardial protection
mechanism against sudden ischemia. According to
some other investigators, the absence of collateral
circulation cannot be the only or main mechanism
of CR [7]. In the age of thrombolysis in AMI treat-
ment, the role of fibrinolytic drugs in CR was pos-
tulated as playing a role in collagen destruction.
Becker et al, based on large registry experience
including over 350,000 patients, suggested that
thrombolytic therapy does not evoke but only ac-
celerates CR [4, 5]. Now, in the age of PCI, this is
not confirmed by investigators. In addition, we did
not observe the advantages of fibrinolysis frequen-
cy in CR patients. Moreover, there were no differ-
ences in abciximab treatment between both groups.
In the comparative analysis considering concomitant
diseases, there were no significant differences in
Figure 2. Probability of cardiac rupture (CR) in acute
myocardial infarction (AMI) women considering age
and time of AMI pain.
Figure 1. The probability of cardiac rupture (CR) in acu-
te myocardial infarction (AMI) patient considering age
and time of AMI pain.
542
Cardiology Journal 2007, Vol. 14, No. 6
www.cardiologyjournal.org
the presence of arterial hypertension and diabetes
mellitus between both groups. The determination
of risk factors plays an important role in the treat-
ment of AMI patients: it allows the isolation of
a group with increased CR risk (old age, female gen-
der) and emphasizes the need for special supervi-
sion. The provided analysis also confirmed the role
of shortening the time to AMI treatment for CR
prevention.
Conclusions
Cardiac rupture is a common, fatal AMI com-
plication. Old age, female gender and a long time
from the onset of symptoms to AMI treatment are
independent factors of CR in PCI patients. In-
creased length of time from the onset of symptoms
to PCI is a risk factor of CR independent of previ-
ous fibrinolysis.
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